ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES

ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES was reported 14752 times

These side effects are most commonly reported by patients taking ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES:

# Side effect Count
0 DRUG INEFFECTIVE 1480
1 NAUSEA 1382
2 HEADACHE 1247
3 FATIGUE 1102
4 DIARRHOEA 1100
5 OFF LABEL USE 1033
6 DYSPNOEA 1027
7 PAIN 990
8 CHRONIC KIDNEY DISEASE 861
9 ARTHRALGIA 825
10 MALAISE 776
11 ACUTE KIDNEY INJURY 748
12 VOMITING 691
13 COUGH 661
14 PNEUMONIA 634
15 PYREXIA 623
16 FALL 614
17 DIZZINESS 601
18 ANXIETY 587
19 RASH 581
20 ASTHENIA 580
21 PRURITUS 545
22 HYPERTENSION 539
23 ABDOMINAL PAIN UPPER 514
24 WEIGHT DECREASED 509
25 GASTROOESOPHAGEAL REFLUX DISEASE 501
26 HYPERHIDROSIS 485
27 BACK PAIN 467
28 CONDITION AGGRAVATED 452
29 MUSCULAR WEAKNESS 439
30 PRODUCT USE IN UNAPPROVED INDICATION 431
31 PAIN IN EXTREMITY 418
32 HYPERSENSITIVITY 415
33 ABDOMINAL DISCOMFORT 403
34 RHEUMATOID ARTHRITIS 397
35 ARTHRITIS 394
36 CHEST PAIN 384
37 ABDOMINAL PAIN 383
38 RENAL FAILURE 377
39 CONFUSIONAL STATE 376
40 ASTHMA 366
41 NASOPHARYNGITIS 366
42 PALPITATIONS 354
43 SINUSITIS 353
44 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 351
45 DRUG INTERACTION 350
46 DRUG HYPERSENSITIVITY 349
47 INSOMNIA 348
48 DYSPHAGIA 330
49 FEELING ABNORMAL 330
50 NEPHROLITHIASIS 325
51 DEATH 322
52 DRUG INTOLERANCE 315
53 CEREBROVASCULAR ACCIDENT 299
54 PRODUCT DOSE OMISSION ISSUE 298
55 DEHYDRATION 295
56 DEPRESSION 294
57 COVID-19 293
58 WHEEZING 289
59 HYPOTENSION 287
60 INFECTION 284
61 PERIPHERAL SWELLING 284
62 GASTROINTESTINAL DISORDER 282
63 BLOOD PRESSURE INCREASED 281
64 ANAEMIA 278
65 FIBROMYALGIA 276
66 NIGHTMARE 273
67 ANGIOEDEMA 259
68 SLEEP APNOEA SYNDROME 259
69 JOINT SWELLING 258
70 MUSCULOSKELETAL STIFFNESS 255
71 BLOOD GLUCOSE INCREASED 254
72 HYPOTHYROIDISM 251
73 URINARY TRACT INFECTION 249
74 ALOPECIA 245
75 BURNING SENSATION 245
76 MYALGIA 245
77 PRODUCT USE ISSUE 245
78 WEIGHT INCREASED 245
79 CARDIAC DISORDER 244
80 DECREASED APPETITE 243
81 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 243
82 SEDATION 240
83 ERYTHEMA 235
84 INFLUENZA 232
85 INTENTIONAL PRODUCT USE ISSUE 231
86 CONSTIPATION 230
87 INCORRECT DOSE ADMINISTERED 230
88 RENAL DISORDER 230
89 PSORIASIS 228
90 RENAL INJURY 222
91 BLOOD TEST ABNORMAL 219
92 CHEST DISCOMFORT 216
93 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 216
94 OEDEMA PERIPHERAL 216
95 HAEMOGLOBIN DECREASED 214
96 RHINORRHOEA 214
97 ATRIAL FIBRILLATION 212
98 HYPOAESTHESIA 212
99 HEART RATE INCREASED 210
100 NEUROPATHY PERIPHERAL 209
101 MIGRAINE 207
102 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 204
103 COORDINATION ABNORMAL 203
104 CATARACT 200
105 MEMORY IMPAIRMENT 200
106 DYSPEPSIA 199
107 END STAGE RENAL DISEASE 199
108 RESPIRATORY TRACT CONGESTION 198
109 C-REACTIVE PROTEIN INCREASED 195
110 DYSPHONIA 192
111 VISUAL IMPAIRMENT 192
112 INJECTION SITE PAIN 190
113 HEMIPLEGIA 189
114 RHINITIS ALLERGIC 189
115 URTICARIA 189
116 CARPAL TUNNEL SYNDROME 188
117 MYOCARDIAL INFARCTION 188
118 SWELLING FACE 188
119 SOMNOLENCE 186
120 PARAESTHESIA 183
121 DRY SKIN 182
122 SWELLING 182
123 NASAL CONGESTION 181
124 APHASIA 179
125 TACHYCARDIA 177
126 DYSARTHRIA 176
127 MUSCLE SPASMS 176
128 SENSITISATION 176
129 HALLUCINATION 175
130 POLYCYSTIC OVARIES 174
131 SWOLLEN TONGUE 174
132 HOSPITALISATION 173
133 SKIN EXFOLIATION 173
134 BRONCHITIS 170
135 CARDIAC FAILURE CONGESTIVE 170
136 COGNITIVE DISORDER 169
137 BLOOD CREATININE INCREASED 166
138 EATING DISORDER 166
139 CYSTITIS 165
140 INFUSION RELATED REACTION 165
141 TINNITUS 165
142 DRY MOUTH 164
143 HEMIPARESIS 164
144 INFLUENZA LIKE ILLNESS 164
145 GENERAL PHYSICAL HEALTH DETERIORATION 163
146 RENAL IMPAIRMENT 163
147 MUSCLE SPASTICITY 162
148 MOTOR DYSFUNCTION 161
149 AFFECT LABILITY 160
150 SENSORY LOSS 159
151 PERSONALITY DISORDER 158
152 WHITE BLOOD CELL COUNT DECREASED 157
153 OXYGEN SATURATION DECREASED 154
154 CONTRAINDICATED PRODUCT ADMINISTERED 153
155 CAROTID ARTERY THROMBOSIS 152
156 AMNESIA 151
157 GAIT DISTURBANCE 151
158 NEUROLOGIC NEGLECT SYNDROME 151
159 INTERSTITIAL LUNG DISEASE 150
160 SYNCOPE 150
161 SINUS CONGESTION 149
162 ADJUSTMENT DISORDER 147
163 SNEEZING 147
164 OVERDOSE 146
165 ALANINE AMINOTRANSFERASE INCREASED 145
166 CARDIAC FAILURE 145
167 CHILLS 144
168 TREATMENT FAILURE 144
169 ANGINA PECTORIS 141
170 OROPHARYNGEAL PAIN 140
171 SEPSIS 140
172 THERAPEUTIC PRODUCT EFFECT DECREASED 140
173 VISION BLURRED 140
174 METABOLIC ACIDOSIS 139
175 LOSS OF CONSCIOUSNESS 138
176 ULCER 138
177 UPPER RESPIRATORY TRACT INFECTION 138
178 EJECTION FRACTION 137
179 SINUS DISORDER 137
180 THROMBOCYTOPENIA 137
181 TREMOR 137
182 DRY EYE 136
183 LUNG DISORDER 136
184 RHEUMATOID NODULE 136
185 HEPATIC ENZYME INCREASED 133
186 HYPONATRAEMIA 133
187 INTENTIONAL PRODUCT MISUSE 133
188 DIPLOPIA 132
189 SEROTONIN SYNDROME 130
190 TUBULOINTERSTITIAL NEPHRITIS 129
191 SKIN HAEMORRHAGE 127
192 VENTRICULAR TACHYCARDIA 127
193 MUSCULOSKELETAL PAIN 126
194 FLUSHING 125
195 PLATELET COUNT DECREASED 125
196 PULMONARY EMBOLISM 125
197 RESPIRATORY FAILURE 125
198 SUICIDE ATTEMPT 125
199 BLINDNESS 124
200 PERICARDITIS 124
201 RASH PRURITIC 124
202 TRANSIENT ISCHAEMIC ATTACK 124
203 EYE IRRITATION 123
204 PULMONARY OEDEMA 123
205 DISTURBANCE IN ATTENTION 120
206 PLEURAL EFFUSION 120
207 INFLAMMATION 119
208 ABDOMINAL DISTENSION 118
209 INJECTION SITE REACTION 118
210 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 117
211 ADVERSE EVENT 116
212 ILLNESS 115
213 INTENTIONAL OVERDOSE 114
214 RED BLOOD CELL SEDIMENTATION RATE INCREASED 113
215 DIABETES MELLITUS 112
216 EYE PAIN 112
217 PERICARDIAL EFFUSION 112
218 BALANCE DISORDER 111
219 THROAT IRRITATION 110
220 VASCULITIS 109
221 IMPAIRED HEALING 108
222 LIP SWELLING 108
223 KIDNEY INFECTION 107
224 NEPHROPATHY 107
225 NEUTROPENIA 107
226 THERAPEUTIC RESPONSE DECREASED 106
227 EYE PRURITUS 105
228 HERPES ZOSTER 105
229 HYPOKALAEMIA 105
230 LIVER DISORDER 105
231 RED BLOOD CELL COUNT DECREASED 105
232 RENAL FAILURE ACUTE 105
233 ANAPHYLACTIC REACTION 104
234 ARTERIAL OCCLUSIVE DISEASE 104
235 GANGRENE 103
236 MUSCLE TWITCHING 103
237 PRODUCTIVE COUGH 103
238 STRESS 103
239 SKIN ULCER 102
240 MAJOR DEPRESSION 101
241 MALNUTRITION 101
242 ASPARTATE AMINOTRANSFERASE INCREASED 100
243 FACIAL PAIN 99
244 SEPTIC SHOCK 99
245 THROMBOSIS 99
246 BLOOD PRESSURE DECREASED 97
247 SUBARACHNOID HAEMORRHAGE 97
248 CAROTID ARTERY OCCLUSION 96
249 PAIN OF SKIN 96
250 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 96
251 FULL BLOOD COUNT ABNORMAL 95
252 OSTEOARTHRITIS 95
253 PHYSICAL DECONDITIONING 95
254 CONTUSION 94
255 ATRIAL TACHYCARDIA 93
256 ANOSMIA 92
257 CARDIOSPASM 92
258 LOWER RESPIRATORY TRACT INFECTION 92
259 SLEEP TERROR 92
260 OSTEOPOROSIS 91
261 PRURITUS GENITAL 91
262 TENSION HEADACHE 91
263 STOMATITIS 90
264 PALMOPLANTAR KERATODERMA 89
265 TOXICITY TO VARIOUS AGENTS 88
266 ARTHROPATHY 87
267 TOOTH DISORDER 87
268 WHITE BLOOD CELL COUNT INCREASED 87
269 DISCOMFORT 86
270 DYSGEUSIA 86
271 NECK PAIN 86
272 SLEEP DISORDER 86
273 DEEP VEIN THROMBOSIS 85
274 FOOT DEFORMITY 84
275 PULMONARY CONGESTION 84
276 THYROID DISORDER 84
277 INCORRECT PRODUCT ADMINISTRATION DURATION 83
278 VERTIGO 83
279 TOOTH INFECTION 82
280 BLOOD PRESSURE FLUCTUATION 81
281 HOT FLUSH 81
282 RHABDOMYOLYSIS 81
283 ADVERSE DRUG REACTION 80
284 BLOOD PRESSURE DIASTOLIC DECREASED 80
285 BLOOD UREA INCREASED 80
286 FEBRILE NEUTROPENIA 80
287 TYPE 2 DIABETES MELLITUS 80
288 DEPRESSED MOOD 79
289 RESPIRATORY DISTRESS 79
290 TENDERNESS 79
291 DYSPNOEA EXERTIONAL 78
292 NERVE INJURY 78
293 BLOOD ALKALINE PHOSPHATASE INCREASED 77
294 EYE HAEMORRHAGE 77
295 IMPAIRED WORK ABILITY 77
296 FEELING HOT 76
297 RASH MACULO-PAPULAR 76
298 PANCYTOPENIA 75
299 SYNOVIAL CYST 75
300 THERAPY NON-RESPONDER 75
301 DRUG-INDUCED LIVER INJURY 73
302 HYPOMAGNESAEMIA 73
303 FLATULENCE 72
304 BREATH SOUNDS ABNORMAL 71
305 DRUG ERUPTION 71
306 DYSURIA 71
307 ECZEMA 71
308 GASTROINTESTINAL HAEMORRHAGE 71
309 LEUKOPENIA 71
310 BRADYCARDIA 70
311 CARDIAC ARREST 70
312 EJECTION FRACTION ABNORMAL 70
313 MOBILITY DECREASED 70
314 OBSTRUCTIVE AIRWAYS DISORDER 70
315 MULTI-ORGAN DISORDER 69
316 RASH PAPULAR 69
317 BLOOD PRESSURE SYSTOLIC INCREASED 68
318 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 68
319 HYPERKALAEMIA 68
320 OEDEMA 68
321 FUNGAL INFECTION 67
322 HEART RATE DECREASED 67
323 INJECTION SITE ERYTHEMA 67
324 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 67
325 BLOOD GLUCOSE DECREASED 66
326 HUNGER 66
327 OCULAR HYPERAEMIA 66
328 ADRENAL INSUFFICIENCY 65
329 PULMONARY FIBROSIS 65
330 BLOOD CHOLESTEROL INCREASED 63
331 HYPOXIA 63
332 PSORIATIC ARTHROPATHY 63
333 RECTAL HAEMORRHAGE 63
334 RESPIRATORY DISORDER 63
335 SURGERY 63
336 AGITATION 62
337 EPISTAXIS 62
338 JAUNDICE 61
339 OBSTRUCTIVE SLEEP APNOEA SYNDROME 61
340 PRESCRIBED UNDERDOSE 61
341 TENOSYNOVITIS 61
342 COMA 60
343 DISEASE RECURRENCE 60
344 HAEMATOCHEZIA 60
345 HEPATIC FUNCTION ABNORMAL 60
346 JOINT STIFFNESS 60
347 TEMPERATURE INTOLERANCE 60
348 BURSITIS 59
349 CORONARY ARTERY DISEASE 59
350 FLUID RETENTION 59
351 HAEMORRHAGE 59
352 HEPATITIS 59
353 NEOPLASM MALIGNANT 59
354 ASCITES 58
355 GASTRITIS 58
356 SYNOVITIS 58
357 CELLULITIS 57
358 CONJUNCTIVITIS 57
359 DRUG LEVEL INCREASED 57
360 NEUTROPHIL COUNT INCREASED 57
361 PHOTOPHOBIA 57
362 RHINITIS 57
363 CHOLESTASIS 56
364 IMMUNISATION 56
365 MULTIPLE SCLEROSIS 56
366 NEUTROPHIL COUNT DECREASED 56
367 SYSTEMIC LUPUS ERYTHEMATOSUS 56
368 ACUTE MYOCARDIAL INFARCTION 55
369 ATELECTASIS 55
370 BLOOD IRON DECREASED 55
371 POST-TRAUMATIC STRESS DISORDER 55
372 COLITIS ULCERATIVE 54
373 DELIRIUM 54
374 DISEASE PROGRESSION 54
375 HEPATIC STEATOSIS 54
376 JOINT RANGE OF MOTION DECREASED 54
377 UNRESPONSIVE TO STIMULI 54
378 VITAMIN D DEFICIENCY 54
379 GASTRIC DISORDER 53
380 HYPERLIPIDAEMIA 53
381 MALIGNANT NEOPLASM PROGRESSION 53
382 MATERNAL EXPOSURE DURING PREGNANCY 53
383 STAPHYLOCOCCAL INFECTION 53
384 SUICIDAL IDEATION 53
385 CROHN^S DISEASE 52
386 ELECTROCARDIOGRAM QT PROLONGED 52
387 HIATUS HERNIA 52
388 HYPOCALCAEMIA 52
389 MULTIPLE ORGAN DYSFUNCTION SYNDROME 52
390 ROAD TRAFFIC ACCIDENT 52
391 SEASONAL ALLERGY 52
392 SINUS TACHYCARDIA 52
393 DEMYELINATION 51
394 INTESTINAL OBSTRUCTION 51
395 PANCREATITIS 51
396 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 51
397 PROTEINURIA 51
398 BASAL CELL CARCINOMA 50
399 BONE DENSITY DECREASED 50
400 DIALYSIS 50
401 GLYCOSYLATED HAEMOGLOBIN INCREASED 50
402 LACTIC ACIDOSIS 50
403 RASH ERYTHEMATOUS 50
404 GAMMA-GLUTAMYLTRANSFERASE INCREASED 49
405 HYPOGLYCAEMIA 49
406 INTERNATIONAL NORMALISED RATIO INCREASED 49
407 INTERVERTEBRAL DISCITIS 49
408 JOINT EFFUSION 49
409 LETHARGY 49
410 MEDICATION ERROR 49
411 MIOSIS 49
412 NEPHRECTOMY 49
413 SKIN DISCOLOURATION 49
414 EMOTIONAL DISTRESS 48
415 GASTRIC ULCER 48
416 HEPATIC FAILURE 48
417 PANCREATITIS ACUTE 48
418 URINARY INCONTINENCE 48
419 DISORIENTATION 47
420 LIMB DISCOMFORT 47
421 SPINAL DISORDER 47
422 ACUTE RESPIRATORY FAILURE 46
423 CHOLECYSTITIS ACUTE 46
424 CREPITATIONS 46
425 ELECTRIC SHOCK 46
426 HAEMOPTYSIS 46
427 POLLAKIURIA 46
428 BACTERIAL INFECTION 45
429 BONE PAIN 45
430 EOSINOPHILIA 45
431 HAEMATURIA 45
432 INJECTION SITE PRURITUS 45
433 LIVER FUNCTION TEST ABNORMAL 45
434 LYMPHOCYTE COUNT DECREASED 45
435 SEIZURE 45
436 AGRANULOCYTOSIS 44
437 BREAST CANCER 44
438 CONVULSION 44
439 EAR INFECTION 44
440 FEELING JITTERY 44
441 PRODUCT SUBSTITUTION ISSUE 44
442 SKIN LESION 44
443 VITAMIN B12 DEFICIENCY 44
444 ANKLE FRACTURE 43
445 BLOOD URIC ACID INCREASED 43
446 DIVERTICULITIS 43
447 DRUG DOSE OMISSION 43
448 ILL-DEFINED DISORDER 43
449 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 43
450 ISCHAEMIC STROKE 43
451 LYMPHADENOPATHY 43
452 MUSCULOSKELETAL DISCOMFORT 43
453 ORAL PAIN 43
454 BLISTER 42
455 HEPATIC CYTOLYSIS 42
456 PANNICULITIS 42
457 PNEUMONIA ASPIRATION 42
458 UNDERDOSE 42
459 COLITIS 41
460 INTENTIONAL DOSE OMISSION 41
461 LARGE INTESTINE POLYP 41
462 RASH MACULAR 41
463 SKIN DISORDER 41
464 WOUND 41
465 ACCIDENTAL OVERDOSE 40
466 BLOOD PRESSURE SYSTOLIC DECREASED 40
467 BONE MARROW FAILURE 40
468 CHOLELITHIASIS 40
469 DACTYLITIS 40
470 FLANK PAIN 40
471 GLOMERULAR FILTRATION RATE INCREASED 40
472 HAEMATOMA 40
473 HEAD INJURY 40
474 HEART RATE IRREGULAR 40
475 INJECTION SITE EXTRAVASATION 40
476 NEPHROGENIC ANAEMIA 40
477 NIGHT SWEATS 40
478 PAIN IN JAW 40
479 PRODUCT USED FOR UNKNOWN INDICATION 40
480 PULMONARY TOXICITY 40
481 RENAL CYST 40
482 ARRHYTHMIA 39
483 DRUG TOLERANCE DECREASED 39
484 GLOSSODYNIA 39
485 HYPERCALCAEMIA 39
486 MONOCYTE COUNT INCREASED 39
487 PANIC ATTACK 39
488 RHEUMATOID FACTOR POSITIVE 39
489 BLOOD PARATHYROID HORMONE DECREASED 38
490 GRANULOCYTE COUNT INCREASED 38
491 JOINT INJURY 38
492 JOINT NOISE 38
493 MOUTH ULCERATION 38
494 NO ADVERSE EVENT 38
495 NOCTURIA 38
496 NODULE 38
497 POST CHOLECYSTECTOMY SYNDROME 38
498 TENOSYNOVITIS STENOSANS 38
499 UNEVALUABLE EVENT 38
500 VITAMIN B12 INCREASED 38
501 BLOOD CREATINE PHOSPHOKINASE INCREASED 37
502 BLOOD IMMUNOGLOBULIN A INCREASED 37
503 HEPATOTOXICITY 37
504 INJECTION SITE BRUISING 37
505 INJECTION SITE SWELLING 37
506 MITRAL VALVE INCOMPETENCE 37
507 POLYP 37
508 RENAL TUBULAR NECROSIS 37
509 RHEUMATOID FACTOR INCREASED 37
510 SCIATICA 37
511 SKIN NECROSIS 37
512 SPEECH DISORDER 37
513 THROAT CLEARING 37
514 BLOOD BILIRUBIN INCREASED 36
515 BLOOD POTASSIUM DECREASED 36
516 EPILEPSY 36
517 EYELID OEDEMA 36
518 GRANULOMA SKIN 36
519 HEPATIC CIRRHOSIS 36
520 INTERVERTEBRAL DISC PROTRUSION 36
521 MOUTH HAEMORRHAGE 36
522 NEOPLASM PROGRESSION 36
523 ORAL HERPES 36
524 PLEURITIC PAIN 36
525 PULMONARY HYPERTENSION 36
526 SKIN BURNING SENSATION 36
527 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 36
528 TREATMENT NONCOMPLIANCE 36
529 URINARY RETENTION 36
530 VIRAL INFECTION 36
531 AFFECTIVE DISORDER 35
532 AREFLEXIA 35
533 ASPARTATE AMINOTRANSFERASE ABNORMAL 35
534 BLOOD SODIUM DECREASED 35
535 DEAFNESS 35
536 HAEMATEMESIS 35
537 HAEMATOCRIT DECREASED 35
538 PRODUCT DOSE OMISSION 35
539 RESPIRATORY TRACT INFECTION 35
540 RETCHING 35
541 THERAPEUTIC RESPONSE SHORTENED 35
542 WHITE BLOOD CELLS URINE POSITIVE 35
543 ACUTE RESPIRATORY DISTRESS SYNDROME 34
544 ANAL ABSCESS 34
545 CUSHINGOID 34
546 DEPRESSED LEVEL OF CONSCIOUSNESS 34
547 MIDDLE INSOMNIA 34
548 MUSCULOSKELETAL CHEST PAIN 34
549 PNEUMONIA HAEMOPHILUS 34
550 PNEUMONITIS 34
551 SCLERITIS 34
552 TENDON RUPTURE 34
553 BODY TEMPERATURE DECREASED 33
554 BRONCHIECTASIS 33
555 CANDIDA INFECTION 33
556 CARDIOMEGALY 33
557 EPIGASTRIC DISCOMFORT 33
558 ERUCTATION 33
559 GAIT INABILITY 33
560 HIP FRACTURE 33
561 IMPAIRED QUALITY OF LIFE 33
562 NERVOUSNESS 33
563 PRODUCT QUALITY ISSUE 33
564 RALES 33
565 THERAPY INTERRUPTED 33
566 TRICUSPID VALVE INCOMPETENCE 33
567 DEFORMITY 32
568 DERMATITIS ATOPIC 32
569 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 32
570 FOETAL EXPOSURE DURING PREGNANCY 32
571 HYPERGLYCAEMIA 32
572 HYPOPHAGIA 32
573 RESTLESS LEGS SYNDROME 32
574 RIB FRACTURE 32
575 ALLERGY TO CHEMICALS 31
576 ALTERED STATE OF CONSCIOUSNESS 31
577 COMPLETED SUICIDE 31
578 DIABETIC NEPHROPATHY 31
579 DIASTOLIC DYSFUNCTION 31
580 DRUG EFFECT LESS THAN EXPECTED 31
581 EXPOSURE DURING PREGNANCY 31
582 HAND DEFORMITY 31
583 LYMPHOMA 31
584 NASAL DISCHARGE DISCOLOURATION 31
585 NIPPLE SWELLING 31
586 PRE-EXISTING CONDITION IMPROVED 31
587 SHOCK 31
588 BRONCHIAL DISORDER 30
589 CARDIAC MURMUR 30
590 CEREBRAL INFARCTION 30
591 EAR PAIN 30
592 FACIAL PARALYSIS 30
593 FREQUENT BOWEL MOVEMENTS 30
594 HALLUCINATION, VISUAL 30
595 HEPATOCELLULAR INJURY 30
596 MELAENA 30
597 NIPPLE PAIN 30
598 PHLEBITIS 30
599 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 30
600 STEVENS-JOHNSON SYNDROME 30
601 THROAT TIGHTNESS 30
602 TOXIC EPIDERMAL NECROLYSIS 30
603 ANHEDONIA 29
604 ANTINUCLEAR ANTIBODY POSITIVE 29
605 BODY TEMPERATURE INCREASED 29
606 BUNION OPERATION 29
607 CARDIO-RESPIRATORY ARREST 29
608 COVID-19 PNEUMONIA 29
609 DEMENTIA 29
610 DYSLIPIDAEMIA 29
611 FEMUR FRACTURE 29
612 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 29
613 LEFT VENTRICULAR HYPERTROPHY 29
614 LIMB INJURY 29
615 MAST CELL ACTIVATION SYNDROME 29
616 NEEDLE ISSUE 29
617 OSTEONECROSIS 29
618 PLATELET COUNT INCREASED 29
619 TONGUE BITING 29
620 BRAIN SCAN ABNORMAL 28
621 CHRONIC SINUSITIS 28
622 DEVICE ISSUE 28
623 DRUG DELIVERY SYSTEM MALFUNCTION 28
624 FOLLICULITIS 28
625 FOOT OPERATION 28
626 HERNIA 28
627 HUMAN RHINOVIRUS TEST POSITIVE 28
628 INFUSION SITE ERYTHEMA 28
629 INJECTION SITE HAEMORRHAGE 28
630 INJECTION SITE IRRITATION 28
631 MOVEMENT DISORDER 28
632 SPINAL OSTEOARTHRITIS 28
633 SUPRAVENTRICULAR TACHYCARDIA 28
634 TOXIC SKIN ERUPTION 28
635 VIRAL TEST POSITIVE 28
636 BLOOD PRESSURE ABNORMAL 27
637 BRONCHIAL HAEMORRHAGE 27
638 BRONCHIAL NEOPLASM 27
639 CEREBRAL ARTERY THROMBOSIS 27
640 EYE SWELLING 27
641 GRANULOMA 27
642 INJECTION SITE MASS 27
643 IRON DEFICIENCY ANAEMIA 27
644 LIVER INJURY 27
645 MUCOSAL INFLAMMATION 27
646 NASAL TURBINATE HYPERTROPHY 27
647 NEURALGIA 27
648 PRESYNCOPE 27
649 QUALITY OF LIFE DECREASED 27
650 RESTLESSNESS 27
651 RHONCHI 27
652 VENTRICULAR HYPOKINESIA 27
653 WRONG TECHNIQUE IN DRUG USAGE PROCESS 27
654 ACCIDENT 26
655 ANAPHYLACTIC SHOCK 26
656 CYST 26
657 EJECTION FRACTION DECREASED 26
658 ENDOMETRIAL ABLATION 26
659 FEEDING DISORDER 26
660 GASTRIC CANCER 26
661 GASTROINTESTINAL MOTILITY DISORDER 26
662 GENERALISED OEDEMA 26
663 INSURANCE ISSUE 26
664 MENTAL DISORDER 26
665 PRODUCT ADMINISTRATION INTERRUPTED 26
666 UPPER-AIRWAY COUGH SYNDROME 26
667 ANAEMIA MACROCYTIC 25
668 CAROTID ARTERIOSCLEROSIS 25
669 CHOLANGITIS 25
670 CORONARY ARTERY OCCLUSION 25
671 ENCEPHALOPATHY 25
672 FOOT FRACTURE 25
673 GASTROENTERITIS VIRAL 25
674 INFUSION SITE PAIN 25
675 INJECTION SITE WARMTH 25
676 IRRITABLE BOWEL SYNDROME 25
677 LACRIMATION INCREASED 25
678 OSTEOPENIA 25
679 SKIN LACERATION 25
680 SKIN PLAQUE 25
681 SYNOVIAL FLUID ANALYSIS 25
682 WOUND INFECTION 25
683 ABNORMAL DREAMS 24
684 BLOOD LACTATE DEHYDROGENASE INCREASED 24
685 CAROTID ARTERY STENOSIS 24
686 CYTOLYTIC HEPATITIS 24
687 DECREASED IMMUNE RESPONSIVENESS 24
688 ELECTROLYTE IMBALANCE 24
689 ENCEPHALITIS 24
690 ESSENTIAL HYPERTENSION 24
691 GASTRIC POLYPS 24
692 GASTROENTERITIS 24
693 HELICOBACTER INFECTION 24
694 HYPERSOMNIA 24
695 HYPERTENSIVE NEPHROPATHY 24
696 HYPOALBUMINAEMIA 24
697 INJURY 24
698 MYELOSUPPRESSION 24
699 POOR QUALITY SLEEP 24
700 SPINAL FRACTURE 24
701 TASTE DISORDER 24
702 TRANSAMINASES INCREASED 24
703 VARICOSE VEIN 24
704 ABDOMINAL PAIN LOWER 23
705 DERMATITIS BULLOUS 23
706 DISABILITY 23
707 DRUG ABUSE 23
708 ECONOMIC PROBLEM 23
709 EMPHYSEMA 23
710 EYE INFECTION 23
711 FACE OEDEMA 23
712 FAECES DISCOLOURED 23
713 FOETAL GROWTH RESTRICTION 23
714 HEPATIC PAIN 23
715 HYPERTHERMIA 23
716 HYPOACUSIS 23
717 INTERVERTEBRAL DISC DEGENERATION 23
718 JOINT DISLOCATION 23
719 LOSS OF EMPLOYMENT 23
720 LUNG INFILTRATION 23
721 PHARYNGEAL SWELLING 23
722 SYNOVIAL DISORDER 23
723 CLOSTRIDIUM DIFFICILE INFECTION 22
724 DYSSTASIA 22
725 FEAR 22
726 HYPERCHOLESTEROLAEMIA 22
727 LOCALISED INFECTION 22
728 MULTIPLE SCLEROSIS RELAPSE 22
729 MYOCLONUS 22
730 OBESITY 22
731 OVARIAN CYST 22
732 PHARYNGITIS 22
733 PULMONARY MASS 22
734 REBOUND ACID HYPERSECRETION 22
735 SKIN FISSURES 22
736 SUBDURAL HAEMATOMA 22
737 UPPER GASTROINTESTINAL HAEMORRHAGE 22
738 AGGRESSION 21
739 AORTIC VALVE INCOMPETENCE 21
740 APHTHOUS ULCER 21
741 BLOOD ALBUMIN DECREASED 21
742 BLOOD POTASSIUM INCREASED 21
743 BLOOD TRIGLYCERIDES INCREASED 21
744 BLOOD URINE PRESENT 21
745 CHOKING 21
746 DRUG DEPENDENCE 21
747 EXPOSURE VIA SKIN CONTACT 21
748 GLAUCOMA 21
749 GOUT 21
750 INJECTION SITE INDURATION 21
751 LIVER FUNCTION TEST INCREASED 21
752 MENTAL STATUS CHANGES 21
753 MUSCLE CONTRACTIONS INVOLUNTARY 21
754 OESOPHAGITIS 21
755 PALLOR 21
756 POLYARTHRITIS 21
757 PRODUCT DOSE OMISSION IN ERROR 21
758 SENSITIVITY TO WEATHER CHANGE 21
759 THERAPEUTIC RESPONSE UNEXPECTED 21
760 VITAMIN D DECREASED 21
761 ANGIOPATHY 20
762 BACK DISORDER 20
763 BONE DISORDER 20
764 CHROMATURIA 20
765 CYTOKINE RELEASE SYNDROME 20
766 DERMATITIS 20
767 DISSEMINATED INTRAVASCULAR COAGULATION 20
768 EOSINOPHIL COUNT INCREASED 20
769 GASTROINTESTINAL TOXICITY 20
770 GINGIVAL PAIN 20
771 HYPOPNOEA 20
772 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20
773 LEUKOCYTOSIS 20
774 MULTIPLE ALLERGIES 20
775 MYOCARDIAL ISCHAEMIA 20
776 POST PROCEDURAL COMPLICATION 20
777 SPUTUM DISCOLOURED 20
778 ATTENTION DEFICIT HYPERACTIVITY DISORDER 19
779 BURNS SECOND DEGREE 19
780 CARDIAC DISCOMFORT 19
781 CHOLECYSTITIS 19
782 DERMATITIS CONTACT 19
783 DYSPNOEA AT REST 19
784 HELICOBACTER GASTRITIS 19
785 HEPATITIS ACUTE 19
786 HEPATOJUGULAR REFLUX 19
787 ILEUS 19
788 LIPASE INCREASED 19
789 LUNG NEOPLASM MALIGNANT 19
790 POOR VENOUS ACCESS 19
791 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 19
792 PSYCHOTIC DISORDER 19
793 SOMNAMBULISM 19
794 SYSTOLIC DYSFUNCTION 19
795 THIRST 19
796 ACNE 18
797 APHONIA 18
798 BLOOD CALCIUM DECREASED 18
799 BLOOD PRESSURE DIASTOLIC ABNORMAL 18
800 BRONCHOSPASM 18
801 CATARRH 18
802 CEREBRAL HAEMORRHAGE 18
803 CHOLECYSTECTOMY 18
804 CONCUSSION 18
805 CYTOMEGALOVIRUS INFECTION 18
806 DIVERTICULUM 18
807 DRUG TOXICITY 18
808 DYSKINESIA 18
809 ELECTROCARDIOGRAM Q WAVE ABNORMAL 18
810 EXTRA DOSE ADMINISTERED 18
811 EYE DISORDER 18
812 FOETAL ANAEMIA 18
813 FULL BLOOD COUNT DECREASED 18
814 GASTROINTESTINAL PAIN 18
815 HAEMOGLOBIN INCREASED 18
816 HAEMORRHOIDS 18
817 HEAD DISCOMFORT 18
818 HEPATOMEGALY 18
819 HYPERAESTHESIA 18
820 HYPERCHLORHYDRIA 18
821 IMPAIRED GASTRIC EMPTYING 18
822 INFUSION SITE PRURITUS 18
823 INGROWING NAIL 18
824 INJECTION SITE RASH 18
825 MOOD ALTERED 18
826 MULTI-ORGAN FAILURE 18
827 NASAL DRYNESS 18
828 OROPHARYNGEAL DISCOMFORT 18
829 PLASMA CELL MYELOMA 18
830 PLEURISY 18
831 POLYURIA 18
832 PRURITUS GENERALISED 18
833 ATRIAL FLUTTER 17
834 ATRIOVENTRICULAR BLOCK COMPLETE 17
835 BACTERAEMIA 17
836 BENIGN PROSTATIC HYPERPLASIA 17
837 BLOOD THYROID STIMULATING HORMONE INCREASED 17
838 BOWEL MOVEMENT IRREGULARITY 17
839 CROHN'S DISEASE 17
840 DELUSION 17
841 DRUG EFFECT INCOMPLETE 17
842 ERECTILE DYSFUNCTION 17
843 EXOSTOSIS 17
844 FEELING COLD 17
845 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17
846 HEPATIC ENCEPHALOPATHY 17
847 HYPOPHOSPHATAEMIA 17
848 IMMUNE SYSTEM DISORDER 17
849 INJECTION SITE HYPERSENSITIVITY 17
850 IRRITABILITY 17
851 LUNG OPACITY 17
852 MICTURITION URGENCY 17
853 MUSCLE STRAIN 17
854 OCCULT BLOOD 17
855 ORAL CANDIDIASIS 17
856 PANCREATIC NEUROENDOCRINE TUMOUR 17
857 PAROSMIA 17
858 PNEUMOCYSTIS JIROVECII PNEUMONIA 17
859 PNEUMOTHORAX 17
860 PRODUCT AVAILABILITY ISSUE 17
861 PROTEIN URINE PRESENT 17
862 ROTATOR CUFF SYNDROME 17
863 UPPER LIMB FRACTURE 17
864 ABNORMAL BEHAVIOUR 16
865 ACCIDENTAL EXPOSURE TO PRODUCT 16
866 ACUTE HEPATIC FAILURE 16
867 ASPARTATE AMINOTRANSFERASE 16
868 BASEDOW^S DISEASE 16
869 BIPOLAR DISORDER 16
870 BLOOD GLUCOSE ABNORMAL 16
871 BLOOD PRESSURE SYSTOLIC ABNORMAL 16
872 BUNDLE BRANCH BLOCK LEFT 16
873 CARDIAC FAILURE CHRONIC 16
874 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 16
875 DEVICE MALFUNCTION 16
876 DUODENAL ULCER PERFORATION 16
877 FRACTURE 16
878 HAEMOLYSIS 16
879 INCONTINENCE 16
880 INCREASED APPETITE 16
881 IRON DEFICIENCY 16
882 MENISCUS INJURY 16
883 MUSCLE TIGHTNESS 16
884 NEPHRITIC SYNDROME 16
885 PEMPHIGUS 16
886 PHARYNGOLARYNGEAL PAIN 16
887 RHINALGIA 16
888 SMALL INTESTINAL OBSTRUCTION 16
889 VENTRICULAR EXTRASYSTOLES 16
890 C-REACTIVE PROTEIN ABNORMAL 15
891 CATHETER SITE PAIN 15
892 CYTOPENIA 15
893 ENTHESOPATHY 15
894 ESCHERICHIA INFECTION 15
895 FACET JOINT SYNDROME 15
896 GRAND MAL CONVULSION 15
897 HAEMORRHAGE FOETAL 15
898 HEPATITIS VIRAL 15
899 HYPERPARATHYROIDISM SECONDARY 15
900 HYPOAESTHESIA ORAL 15
901 HYSTERECTOMY 15
902 INCORRECT DRUG ADMINISTRATION DURATION 15
903 INITIAL INSOMNIA 15
904 INTESTINAL PERFORATION 15
905 JAW CLICKING 15
906 KNEE ARTHROPLASTY 15
907 LUNG INFECTION 15
908 MANIA 15
909 METASTASES TO LIVER 15
910 MOOD SWINGS 15
911 MYOPATHY 15
912 NERVE COMPRESSION 15
913 ORTHOSTATIC HYPOTENSION 15
914 PARAESTHESIA ORAL 15
915 PERITONITIS 15
916 PNEUMONIA BACTERIAL 15
917 PROCEDURAL PAIN 15
918 PSEUDOMONAL SEPSIS 15
919 SERUM FERRITIN INCREASED 15
920 THERAPY PARTIAL RESPONDER 15
921 TOXIC ENCEPHALOPATHY 15
922 ANOREXIA 14
923 BACK INJURY 14
924 BLOOD IMMUNOGLOBULIN E INCREASED 14
925 BRUXISM 14
926 CARDIAC TAMPONADE 14
927 CARDIOGENIC SHOCK 14
928 CRYING 14
929 DENTAL RESTORATION FAILURE 14
930 DRUG EFFECT DECREASED 14
931 EYE DISCHARGE 14
932 GLOSSITIS 14
933 HAEMODYNAMIC INSTABILITY 14
934 HAEMOLYTIC ANAEMIA 14
935 HEPATOSPLENOMEGALY 14
936 HYPERNATRAEMIA 14
937 HYPERTHYROIDISM 14
938 IMMUNODEFICIENCY 14
939 INFUSION SITE HAEMORRHAGE 14
940 LEFT VENTRICULAR DYSFUNCTION 14
941 LEFT VENTRICULAR FAILURE 14
942 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 14
943 NERVOUS SYSTEM DISORDER 14
944 OCULAR DISCOMFORT 14
945 PAPULE 14
946 PELVIC FRACTURE 14
947 PELVIC PAIN 14
948 POLYNEUROPATHY 14
949 PRODUCT TASTE ABNORMAL 14
950 PSEUDOMONAS INFECTION 14
951 PYELONEPHRITIS 14
952 RENAL ATROPHY 14
953 RENAL FAILURE CHRONIC 14
954 RESPIRATORY RATE INCREASED 14
955 RHEUMATIC FEVER 14
956 SENSATION OF FOREIGN BODY 14
957 SENSORY DISTURBANCE 14
958 TACHYPNOEA 14
959 TOOTH EXTRACTION 14
960 TUMOUR LYSIS SYNDROME 14
961 URINE LEUKOCYTE ESTERASE POSITIVE 14
962 WEIGHT FLUCTUATION 14
963 ALCOHOL POISONING 13
964 ANGER 13
965 ANKYLOSING SPONDYLITIS 13
966 BLOOD MAGNESIUM DECREASED 13
967 BODY HEIGHT DECREASED 13
968 BUNDLE BRANCH BLOCK RIGHT 13
969 CHOKING SENSATION 13
970 CORONARY ARTERY STENOSIS 13
971 DECREASED ACTIVITY 13
972 DEVICE OCCLUSION 13
973 DEVICE RELATED INFECTION 13
974 DIABETIC KETOACIDOSIS 13
975 DIVERTICULUM INTESTINAL 13
976 DRUG WITHDRAWAL SYNDROME 13
977 GLOMERULAR FILTRATION RATE DECREASED 13
978 GRIP STRENGTH DECREASED 13
979 HAEMATOMA MUSCLE 13
980 HAEMODIALYSIS 13
981 HYDRONEPHROSIS 13
982 HYPERTRIGLYCERIDAEMIA 13
983 HYPERURICAEMIA 13
984 IMMUNOSUPPRESSION 13
985 IMPAIRED DRIVING ABILITY 13
986 INFUSION SITE SWELLING 13
987 INJECTION SITE HAEMATOMA 13
988 INJECTION SITE URTICARIA 13
989 LIGAMENT SPRAIN 13
990 LOWER LIMB FRACTURE 13
991 NEPHROPATHY TOXIC 13
992 NEPHROSCLEROSIS 13
993 NEPHROTIC SYNDROME 13
994 ONYCHOMADESIS 13
995 PERIPHERAL SENSORY NEUROPATHY 13
996 POSTOPERATIVE WOUND INFECTION 13
997 PRODUCT PRESCRIBING ISSUE 13
998 RASH GENERALISED 13
999 SHOCK HAEMORRHAGIC 13